Table 2 Final list of eligible clinical studies
From: Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review
Trial ID/DOI | Public title |
|---|---|
ChiCTR-IOR-16009658 | A precision medicine-based clinical study of screening targeted drug combined with chemotherapy for the treatment of primary advanced ovarian cancer |
NCT03832153 | Pan-Cardio-Genetics Clot Assessment in Acute Coronary Syndromes |
NCT03890614 | Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid) |
NCT04755907 | 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases |
NCT04925323 | A dermo-epidermal autologous skin substitute for further therapeutic use (BIOPSKIN) |
ChiCTR2200066886 | Clinical application of 3D bioprinted organoid drug screen in adjuvant chemotherapy of pancreatic cancer |
NCT05955092 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma |
NCT04399239 | AuriNovo for Auricular Reconstruction |
10.1177/15347346211045625 | Management of Diabetic Foot Ulcer with MA-ECM (Minimally Manipulated Autologous Extracellular Matrix) Using 3D Bioprinting Technology - An Innovative Approach |
ChiCTR2100049901 | Study of the safety and efficacy of autologous stem cell 3D bioprinted blood vessels for vascular replacement in patients with peripheral limb arterial disease |
NCT06051747 | Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea) |